The U.S. Food and Drug Administration (FDA) has placed a clinical hold on Kezar Life Sciences’ zetomipzomib, an ...

In a new study, researchers looked to identify unique biomarkers and shared microbial mechanisms among different autoimmune ...

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).

A support group is a gathering of people facing common issues to share what’s troubling them. Through the sharing of experiences, they can offer support, encouragement, and comfort to the other group ...

In a new study, researchers examined children with childhood-onset systemic lupus erythematosus (cSLE) and the association between race and social determinants of health (SDOH) on the individual or ...

Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE). Continue ...

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...